June 15, 2017 / 1:36 PM / a month ago

BRIEF-Immune Pharmaceuticals signs agreement to regain worldwide rights for Ceplene

1 Min Read

June 15 (Reuters) - Immune Pharmaceuticals Inc-

* Immune Pharmaceuticals signs agreement to regain worldwide rights for Ceplene

* Immune Pharmaceuticals Inc - under terms of acquisition agreement, immune has agreed to pay mylan a fixed price, which is payable in installments

* Immune Pharmaceuticals Inc - ‍cytovia intends to pursue continued development of ceplene towards potential regulatory approval in united states​

* Immune Pharmaceuticals - intends, through its immuno-oncology subsidary, cytovia inc to undertake commercialization efforts in europe, asia, latin america

* Immune Pharmaceuticals - assets acquired include rights to marketing authorizations, trademarks, patents, other intellectual property related to ceplene

* Immune Pharmaceuticals Inc - cytovia intends to pursue continued development of ceplene towards potential regulatory approval in united states Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below